Physostigmine is usually administered intravenously. The typical dose is 1-2 mg in adults, administered slowly over 5 minutes. In pediatric patients, the dose is generally 0.02 mg/kg. Rapid administration can lead to serious side effects such as bradycardia, seizures, or cholinergic crisis.